Chris Ockenhouse

1.6k total citations
19 papers, 860 citations indexed

About

Chris Ockenhouse is a scholar working on Public Health, Environmental and Occupational Health, Immunology and Molecular Biology. According to data from OpenAlex, Chris Ockenhouse has authored 19 papers receiving a total of 860 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Public Health, Environmental and Occupational Health, 6 papers in Immunology and 5 papers in Molecular Biology. Recurrent topics in Chris Ockenhouse's work include Malaria Research and Control (15 papers), Mosquito-borne diseases and control (11 papers) and vaccines and immunoinformatics approaches (4 papers). Chris Ockenhouse is often cited by papers focused on Malaria Research and Control (15 papers), Mosquito-borne diseases and control (11 papers) and vaccines and immunoinformatics approaches (4 papers). Chris Ockenhouse collaborates with scholars based in United States, United Kingdom and Switzerland. Chris Ockenhouse's co-authors include H L Shear, Dan Knowles, John W. Barnwell, Seymour Schulman, GA Jamieson, F. Klotz, Narendra N. Tandon, Marc Lievens, Kent E. Kester and D. Gray Heppner and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and PLoS ONE.

In The Last Decade

Chris Ockenhouse

19 papers receiving 816 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Chris Ockenhouse 652 296 172 139 70 19 860
Jean‐Louis Pérignon 461 0.7× 252 0.9× 234 1.4× 113 0.8× 94 1.3× 33 795
Marjorie Mauduit 606 0.9× 433 1.5× 160 0.9× 130 0.9× 43 0.6× 15 834
Joanne M. Chesson 590 0.9× 246 0.8× 153 0.9× 111 0.8× 111 1.6× 9 744
Christopher Keller 630 1.0× 429 1.4× 191 1.1× 131 0.9× 50 0.7× 23 1.0k
W. Wollish 656 1.0× 299 1.0× 164 1.0× 134 1.0× 109 1.6× 8 821
Taís Nóbrega de Sousa 572 0.9× 182 0.6× 138 0.8× 142 1.0× 69 1.0× 50 807
Venkatachalam Udhayakumar 808 1.2× 439 1.5× 143 0.8× 149 1.1× 124 1.8× 34 1.1k
Ambroise D. Ahouidi 607 0.9× 186 0.6× 122 0.7× 127 0.9× 50 0.7× 42 725
Kirsten Moll 563 0.9× 262 0.9× 113 0.7× 75 0.5× 66 0.9× 34 685
Marthe C. D’Ombrain 483 0.7× 388 1.3× 260 1.5× 141 1.0× 70 1.0× 10 815

Countries citing papers authored by Chris Ockenhouse

Since Specialization
Citations

This map shows the geographic impact of Chris Ockenhouse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chris Ockenhouse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chris Ockenhouse more than expected).

Fields of papers citing papers by Chris Ockenhouse

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chris Ockenhouse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chris Ockenhouse. The network helps show where Chris Ockenhouse may publish in the future.

Co-authorship network of co-authors of Chris Ockenhouse

This figure shows the co-authorship network connecting the top 25 collaborators of Chris Ockenhouse. A scholar is included among the top collaborators of Chris Ockenhouse based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chris Ockenhouse. Chris Ockenhouse is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
2.
Challenger, Joseph D., Rob ter Heine, Giovanni Charles, et al.. (2023). Modeling the Impact of a Highly Potent Plasmodium falciparum Transmission-Blocking Monoclonal Antibody in Areas of Seasonal Malaria Transmission. The Journal of Infectious Diseases. 228(2). 212–223. 4 indexed citations
3.
Camponovo, Flavia, Chris Ockenhouse, Cynthia Lee, & Melissa A. Penny. (2019). Mass campaigns combining antimalarial drugs and anti-infective vaccines as seasonal interventions for malaria control, elimination and prevention of resurgence: a modelling study. BMC Infectious Diseases. 19(1). 920–920. 17 indexed citations
4.
Nielsen, Carolyn M., Johan Vekemans, Marc Lievens, et al.. (2018). RTS,S malaria vaccine efficacy and immunogenicity during Plasmodium falciparum challenge is associated with HLA genotype. Vaccine. 36(12). 1637–1642. 33 indexed citations
5.
Roestenberg, Meta, Benjamin Mordmüller, Chris Ockenhouse, et al.. (2017). The frontline of controlled human malaria infections: A report from the controlled human infection models Workshop in Leiden University Medical Centre 5 May 2016. Vaccine. 35(51). 7065–7069. 14 indexed citations
6.
Lee, Shwu‐Maan, Chia‐Kuei Wu, Jordan Plieskatt, et al.. (2016). Assessment of Pfs25 expressed from multiple soluble expression platforms for use as transmission-blocking vaccine candidates. Malaria Journal. 15(1). 405–405. 36 indexed citations
7.
Lell, Bertrand, Sélidji Todagbé Agnandji, Kwaku Poku Asante, et al.. (2015). The effect of immunization schedule with the malaria vaccine candidate RTS,S/AS01E on protective efficacy and anti-circumsporozoite protein antibody avidity in African infants. Malaria Journal. 14(1). 72–72. 21 indexed citations
8.
Talley, Angela K., Sara A. Healy, Olivia Finney, et al.. (2014). Safety and Comparability of Controlled Human Plasmodium falciparum Infection by Mosquito Bite in Malaria-Naïve Subjects at a New Facility for Sporozoite Challenge. PLoS ONE. 9(11). e109654–e109654. 15 indexed citations
9.
Ockenhouse, Chris, et al.. (2014). Controlled Human Malaria Infection. The Journal of Infectious Diseases. 209(suppl 2). S40–S45. 60 indexed citations
10.
Waitumbi, John, Samuel B. Anyona, Mark E. Polhemus, et al.. (2009). Impact of RTS,S/AS02A and RTS,S/AS01B on Genotypes of P. falciparum in Adults Participating in a Malaria Vaccine Clinical Trial. PLoS ONE. 4(11). e7849–e7849. 39 indexed citations
11.
Moorthy, Vasee, C. L. Diggs, Michael F. Good, et al.. (2009). Report of a Consultation on the Optimization of Clinical Challenge Trials for Evaluation of Candidate Blood Stage Malaria Vaccines, 18–19 March 2009, Bethesda, MD, USA. Vaccine. 27(42). 5719–5725. 36 indexed citations
12.
Heppner, D. Gray, et al.. (2001). New World monkey efficacy trials for malaria vaccine development: critical path or detour?. Trends in Parasitology. 17(9). 419–425. 17 indexed citations
13.
Vogelgesang, Scott A., et al.. (1995). Listeria monocytogenes infection in a patient treated with methotrexate for rheumatoid arthritis.. PubMed. 22(4). 786–7. 6 indexed citations
14.
15.
Ockenhouse, Chris, F. Klotz, Narendra N. Tandon, & GA Jamieson. (1991). Sequestrin, a CD36 recognition protein on Plasmodium falciparum malaria-infected erythrocytes identified by anti-idiotype antibodies.. Proceedings of the National Academy of Sciences. 88(8). 3175–3179. 97 indexed citations
16.
Barnwell, John W., Chris Ockenhouse, & Dan Knowles. (1985). Monoclonal antibody OKM5 inhibits the in vitro binding of Plasmodium falciparum-infected erythrocytes to monocytes, endothelial, and C32 melanoma cells.. The Journal of Immunology. 135(5). 3494–3497. 172 indexed citations
17.
Ockenhouse, Chris & H L Shear. (1984). Oxidative killing of the intraerythrocytic malaria parasite Plasmodium yoelii by activated macrophages.. The Journal of Immunology. 132(1). 424–431. 101 indexed citations
18.
Ockenhouse, Chris, Seymour Schulman, & H L Shear. (1984). Induction of crisis forms in the human malaria parasite Plasmodium falciparum by gamma-interferon-activated, monocyte-derived macrophages.. The Journal of Immunology. 133(3). 1601–1608. 155 indexed citations
19.
Ockenhouse, Chris & H L Shear. (1983). Malaria-induced lymphokines: stimulation of macrophages for enhanced phagocytosis. Infection and Immunity. 42(2). 733–739. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jean‐Louis Pérignon Breakdown of academic impact, for papers by Marjorie Mauduit Breakdown of academic impact, for papers by Joanne M. Chesson Breakdown of academic impact, for papers by Christopher Keller Breakdown of academic impact, for papers by W. Wollish Breakdown of academic impact, for papers by Taís Nóbrega de Sousa Breakdown of academic impact, for papers by Venkatachalam Udhayakumar Breakdown of academic impact, for papers by Ambroise D. Ahouidi Breakdown of academic impact, for papers by Kirsten Moll Breakdown of academic impact, for papers by Marthe C. D’Ombrain
Rankless by CCL
2026